Increased Psychiatric Morbidity in Men With Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
The DOI matches its Crossref record; 37 of the 40 references it cites were found in a registry or an index.
Abstract
CONTEXT: Reports on psychiatric morbidity in males with congenital adrenal hyperplasia (CAH) are lacking. OBJECTIVE: The aim was to study psychiatric disorders in CAH males. DESIGN, SETTING, AND PARTICIPANTS: We studied males with CAH (21-hydroxylase deficiency, n = 253; CYP21A2 mutations known, n = 185), and compared them with controls (n = 25 300). Data were derived through linkage of national population-based registers. We assessed the subgroups of CYP21A2 genotype separately (null, I2splice, I172N, P30L, and NC), as well as outcomes before and after the introduction of national neonatal screening in 1986. MAIN OUTCOME MEASURES: Psychiatric disorders including attempted and completed suicide (suicidality) were reviewed. RESULTS: Psychiatric disorders (suicidality not included), suicidality, and alcohol misuse were increased in CAH males compared with controls (odds ratios, 1.5, 2.3, and 1.9; 95% confidence intervals, 1.1-2.2, 1.1-5.0, and 1.0-3.5, respectively). In the null genotype group, no increased rates were seen; in the I2splice group, psychiatric disorders, personality disorders, and alcohol misuse were increased; in the I172N group, suicide attempt and drug misuse were increased; and in the P30L and NC groups, psychotic disorders were increased. In CAH males born before the neonatal screening, the rates of psychiatric disorders and suicidality were increased, but only psychotic disorders increased in those born afterward. There was no increased risk for any neurodevelopmental disorder. CONCLUSIONS: CAH males have an increased psychiatric morbidity. Psychiatric morbidity was not raised in the most severe genotype group. Late diagnosis of CAH may explain some of the findings. Those born before the introduction of neonatal screening were more affected, which may be explained by the higher age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mental health of patients with CAH is another example; although most studies focus on females, increased psychiatric symptomatology in both sexes mirrors observations for a wide range of chronic medical conditions (547,594-597).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [595]
In the citing paper
“Epidemiological national registry studies in Sweden have shown that females and males with CAH had an elevated risk of receiving any psychiatric diagnosis [OR, 1.5 (1.1 to 2.2)].”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [378]
In the citing paper
“Girls and women with CAH had an increased risk of reaction to extreme stress and adjustment disorders [OR 2.1, (1.3 to 3.6)] and of alcohol abuse [OR, 2.8 (1.7 to 4.7)] compared with those without the disorder, with the highest risk among those with the most severe genotype.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [378]
In the citing paper
“For boys and men, there were increased rates of reported suicides and suicide attempts [OR, 2.3 (1.1 to 5.0)] and alcohol abuse [OR, 1.9 (1.0 to 3.5)] (377, 378).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [378]
Citations
Cites
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Why are autism spectrum conditions more prevalent in males?
Baron-Cohen, S., Lombardo, M. V., Auyeung, B., Ashwin, E., Chakrabarti, B., & Knickmeyer, R. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001081 · Cited by 754
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Psychiatric Adverse Effects of Corticosteroids
Warrington, T. P., & Bostwick, J. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.10.1361 · Cited by 611
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Congenital Adrenal Hyperplasia: Is there an Effect on Penile Growth?
Levy, J. B., & Husmann, D. A. (1996) · The Journal of Urology · doi:10.1097/00005392-199608001-00060 · Cited by 415
Nonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
Frisén, L., Nordenström, A., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., Möller, A., & Nordenskjöld, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0636 · Cited by 276
Self-citationNordenström, A., Servin, A., Bohlin, G., Larsson, A., & Wedell, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011531 · Cited by 256
Self-citationSellgren, C., Landén, M., Lichtenstein, P., Hultman, C. M., & Långström, N. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01747.x · Cited by 208
Self-citationNordenskjöld, A., Holmdahl, G., Frisén, L., Falhammar, H., Filipsson, H., Thorén, M., Janson, P. O., & Hagenfeldt, K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0556 · Cited by 205
Self-citationGidlöf, S., Falhammar, H., Thilén, A., von Döbeln, U., Ritzén, M., Wedell, A., & Nordenström, A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70007-x · Cited by 187
Self-citationQuality of life in 70 women with disorders of sex development
Johannsen, T. H., Ripa, C. P. L., Mortensen, E. L., & Main, K. M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02294 · Cited by 171
Falhammar, H., Nyström, H. F., Ekström, U., Granberg, S., Wedell, A., & Thorén, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0828 · Cited by 170
Self-citationFalhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167
Self-citationNordenström, A., Frisén, L., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., & Nordenskjöld, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2639 · Cited by 161
Self-citationKuhnle, U., Bullinger, M., & Schwarz, H. P. (1995) · European Journal of Pediatrics · doi:10.1007/bf02276713 · Cited by 153
Fractures and bone mineral density in adult women with 21-hydroxylase deficiency
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151
Self-citationBolanos, S. H., Khan, D. A., Hanczyc, M., Bauer, M. S., Dhanani, N., & Brown, E. S. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61756-5 · Cited by 150
Berenbaum, S. A., Duck, S. C., & Bryk, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6397 · Cited by 138
van der Kamp, H. J., Slijper, F. M. E., & Bullinger, M. (1996) · European Journal of Pediatrics · doi:10.1007/bf01957920 · Cited by 134
Sartorato, P., Zulian, E., Benedini, S., Mariniello, B., Schiavi, F., Bilora, F., Pozzan, G., Greggio, N., Pagnan, A., Mantero, F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1711 · Cited by 132
Berenbaum, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.727 · Cited by 111
Clinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
Self-citationFalhammar, H., Filipsson Nyström, H., Wedell, A., & Thorén, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0877 · Cited by 103
Self-citationNermoen, I., Husebye, E. S., Svartberg, J. B., & Løvås, K. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0284 · Cited by 95
Mooij, C. F., Kroese, J. M., Claahsen‐van der Grinten, H. L., Tack, C. J., & Hermus, A. R. M. M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03690.x · Cited by 92
Chakhtoura, Z., Bachelot, A., Samara-Boustani, D., Ruiz, J.-C., Donadille, B., Dulon, J., Christin-Maître, S., Bouvattier, C., Raux-Demay, M.-C., Bouchard, P., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0887 · Cited by 90
Jääskeläinen, J., & Voutilainen, R. (2000) · Acta Paediatrica · doi:10.1111/j.1651-2227.2000.tb01213.x · Cited by 89
Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia
Falhammar, H., Filipsson Nyström, H., Wedell, A., Brismar, K., & Thorén, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0865 · Cited by 82
Self-citationReisch, N., Hahner, S., Bleicken, B., Flade, L., Pedrosa Gil, F., Loeffler, M., Ventz, M., Hinz, A., Beuschlein, F., Allolio, B., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03920.x · Cited by 78
Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Stimson, R. H., Rees, D. A., Krone, N., Willis, D. S., Conway, G. S., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), U. K. C. A. H. A. S. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12045 · Cited by 70
Nermoen, I., Brønstad, I., Fougner, K. J., Svartberg, J. B., Øksnes, M., Husebye, E. S., & Løvås, K. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0196 · Cited by 45
Malouf, M. A., Inman, A. G., Carr, A. G., Franco, J., & Brooks, L. M. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/253465 · Cited by 41
FALHAMMAR, H., FILIPSSON, H., HOLMDAHL, G., JANSON, P.-O., NORDENSKJÖLD, A., HAGENFELDT, K., & THORÉN, M. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-312 · Cited by 35
Self-citation
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationCaring for individuals with a difference of sex development (DSD): a Consensus Statement
Cools, M., Nordenström, A., Robeva, R., Hall, J., Westerveld, P., Flück, C., Köhler, B., Berra, M., Springer, A., Schweizer, K., et al. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0010-8 · Cited by 461
Self-citationCongenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Falhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204
Self-citation
Metadata
- Authors
- Falhammar, H., Butwicka, A., Landén, M., Lichtenstein, P., Nordenskjöld, A., Nordenström, A., & Frisén, L.
- Affiliations
- Karolinska University Hospital (SE)
- Medical University of Warsaw (PL)
- Karolinska Institutet (SE)
- Corresponding author
- Falhammar, Henrik
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-03-01
- Volume
- 99
- Issue
- 3
- Pages
- E554-E560
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2100099972
- Cited by
- 98
- References
- 40
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 8 · 2020: 16 · 2019: 11 · 2018: 11 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 2
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Karolinska Institutet
- Stockholms Läns Landsting
- Vetenskapsrådet (523-2011-3807)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Social Sciences › Psychology › Social Psychology › LGBTQ Health, Identity, and Policy
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, psychiatric morbidity, suicidality, alcohol abuse, psychosis, personality disorders, drug abuse, newborn screening, delayed diagnosis
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Aged, Aged, 80 and over, Alcoholism, Mental Disorders, Child, Child, Preschool, Genotype, Humans, Infant, Male, Middle Aged, Steroid 21-Hydroxylase, Suicide, Sweden, Case-Control Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.